EUVIMEDExplore EUVIMED
Open access · CC BY-NC-ND 4.0

Phillyrin Attenuates Glucocorticoid‐Induced Osteoporosis by Suppressing Ferroptosis via the Nrf2/Keap1 Axis

Ding‐chao Li, Ke‐jun Zhu, Jian Li, Hai‐Lin Xing, Xiang Zheng, Ming‐jian Wu, Tao Sun

Phytotherapy Research · 2026-11-21

DOI: 10.1002/ptr.70483 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-11-21. Written by Ding‐chao Li and 6 co-authors. 33 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Medical Science and Technology Project of Zhejiang Province.

AbstractBibliographic detailsCiteRelated studies

Abstract (original language)

Extended glucocorticoids treatment is a primary cause of secondary osteoporosis, termed glucocorticoids‐induced osteoporosis (GIOP), characterized by rapid bone loss and an increased fracture risk. Phillyrin (PHI), a natural lignan derived from Forsythia suspensa , possesses well‐documented antioxidant properties; however, its role in GIOP remains unexplored. This study investigates whether PHI protects against dexamethasone (Dex)‐induced ferroptosis and GIOP and elucidates the involvement of the Nrf2/Keap1 signaling axis. A GIOP mouse model was created using intraperitoneal Dex injections, while BMSCs were exposed to Dex in vitro to induce ferroptosis. The effects of PHI were assessed using C11‐BODIPY, FerroOrange, mitochondrial function assays, Western blotting, immunofluorescence, micro‐CT, and histology. Our results revealed that PHI reduced lipid peroxidation, restored mitochondrial membrane potential, and recovered the osteogenic differentiation potential of BMSCs. Mechanistically, PHI promoted Nrf2 nuclear translocation by reducing its association with Keap1, thereby upregulating NQO1, HO‐1, and downstream antioxidant enzymes. Nrf2 knockdown using siRNA eliminated PHI's protective effects in vitro, while in vivo, Nrf2 knockdown lentivirus administration markedly reduced PHI's therapeutic efficacy. In conclusion, this study provides the first evidence that PHI mitigates GIOP by preventing ferroptosis. Mechanistically, PHI activates the Nrf2/Keap1 signaling pathway, upregulating downstream antioxidant enzymes and restoring mitochondrial function to preserve BMSCs' osteogenic potential.

Funding

  • Medical Science and Technology Project of Zhejiang Province

Cite

APA

Li, D., Zhu, K., Li, J., Xing, H., Zheng, X., Wu, M., & Sun, T. (2026). Phillyrin Attenuates Glucocorticoid‐Induced Osteoporosis by Suppressing Ferroptosis via the Nrf2/Keap1 Axis. Phytotherapy Research. https://doi.org/10.1002/ptr.70483

Vancouver

Li D, Zhu K, Li J, Xing H, Zheng X, Wu M, et al. Phillyrin Attenuates Glucocorticoid‐Induced Osteoporosis by Suppressing Ferroptosis via the Nrf2/Keap1 Axis. Phytotherapy Research. 2026. doi:10.1002/ptr.70483

BibTeX
@article{Li2026,
  author = {Li, Ding‐chao and Zhu, Ke‐jun and Li, Jian and Xing, Hai‐Lin and Zheng, Xiang and Wu, Ming‐jian and Sun, Tao},
  title = {Phillyrin Attenuates Glucocorticoid‐Induced Osteoporosis by Suppressing Ferroptosis via the Nrf2/Keap1 Axis},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70483}
}
Start for free →